OpenURL Connection Search

Select item for more details and to access through your institution.

A Phase 2a, Double-Blind, Placebo-controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in Asthma.
Published in:
2021
By:
- Psallidas, Ioannis;
- Backer, Vibeke;
- Kuna, Piotr;
- Palmér, Robert;
- Necander, Sofia;
- Aurell, Malin;
- Korsback, Katarina;
- Taib, Ziad;
- Hashemi, Mahdi;
- Gustafson, Per;
- Asimus, Sara;
- Delaney, Stephen;
- Pardali, Katerina;
- Fanyi Jiang;
- Almquist, Joachim;
- Jackson, Sam;
- Coffman, Robert L.;
- Keeling, David;
- Sethi, Tariq;
- Jiang, Fanyi
Publication type:
journal article
A Phase 2a, Double-Blind, Placebo-Controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in Asthma.
Published in:
American Journal of Respiratory & Critical Care Medicine, 2021, v. 203, n. 3, p. E1, doi. 10.1164/rccm.202001-0133oc
By:
- Psallidas, Ioannis;
- Backer, Vibeke;
- Kuna, Piotr;
- Palmér, Robert;
- Necander, Sofia;
- Aurell, Malin;
- Korsback, Katarina;
- Taib, Ziad;
- Hashemi, Mahdi;
- Gustafson, Per;
- Stephen Delaney, Sara Asimus;
- Pardali, Katerina;
- Jiang, Fanyi;
- Almquist, Joachim;
- Jackson, Sam;
- Coffman, Robert L.;
- Keeling, David;
- Sethi, Tariq
Publication type:
Article
Characterisation of pharmacokinetics, safety and tolerability in a first‐in‐human study for AZD8154, a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease.
Published in:
British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 260, doi. 10.1111/bcp.14956
By:
- Sadiq, Muhammad Waqas;
- Asimus, Sara;
- Belvisi, Maria G.;
- Brailsford, Wayne;
- Fransson, Rebecca;
- Fuhr, Rainard;
- Hagberg, Anette;
- Hashemi, Mahdi;
- Jellesmark Jensen, Tina;
- Jonsson, Julia;
- Keen, Christina;
- Körnicke, Thomas;
- Kristensson, Cecilia;
- Mäenpää, Jukka;
- Necander, Sofia;
- Nemes, Szilárd;
- Betts, Joanne
Publication type:
Article

Found: 3

A Phase 2a, Double-Blind, Placebo-controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in Asthma.

A Phase 2a, Double-Blind, Placebo-Controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in Asthma.

Characterisation of pharmacokinetics, safety and tolerability in a first‐in‐human study for AZD8154, a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease.